Merck's Gardasil taken up by 37% of teen girls

A CDC study shows that, nationwide, 37 percent of teen girls received the human papilloma virus vaccine Gardasil, a mainline defense against cervical cancer. Based on a 2008 telephone survey, researchers found that three New England states boasted the highest vaccine rates--more than 50 percent--while Mississippi, Georgia and South Carolina mustered less than 20 percent. Article

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.